APA

Reber L. L., Starkl P., Balbino B., Sibilano R., Gaudenzio N., Rogalla S., Sensarn S., Kang D., Raghu H., Sokolove J., Robinson W. H., Contag C. H., Tsai M. & Galli S. J. (20171031). The tyrosine kinase inhibitor imatinib mesylate suppresses uric acid crystal-induced acute gouty arthritis in mice. : PloS one.

Chicago

Reber Laurent L, Starkl Philipp, Balbino Bianca, Sibilano Riccardo, Gaudenzio Nicolas, Rogalla Stephan, Sensarn Steven, Kang Dongmin, Raghu Harini, Sokolove Jeremy, Robinson William H, Contag Christopher H, Tsai Mindy and Galli Stephen J. 20171031. The tyrosine kinase inhibitor imatinib mesylate suppresses uric acid crystal-induced acute gouty arthritis in mice. : PloS one.

Harvard

Reber L. L., Starkl P., Balbino B., Sibilano R., Gaudenzio N., Rogalla S., Sensarn S., Kang D., Raghu H., Sokolove J., Robinson W. H., Contag C. H., Tsai M. and Galli S. J. (20171031). The tyrosine kinase inhibitor imatinib mesylate suppresses uric acid crystal-induced acute gouty arthritis in mice. : PloS one.

MLA

Reber Laurent L, Starkl Philipp, Balbino Bianca, Sibilano Riccardo, Gaudenzio Nicolas, Rogalla Stephan, Sensarn Steven, Kang Dongmin, Raghu Harini, Sokolove Jeremy, Robinson William H, Contag Christopher H, Tsai Mindy and Galli Stephen J. The tyrosine kinase inhibitor imatinib mesylate suppresses uric acid crystal-induced acute gouty arthritis in mice. : PloS one. 20171031.